In an EPIC cohort, Sarnik et al. reported that ER+ breast cancer is associated with increased levels of RANKL, rather than OPG, emphasizing different biomarker profiles for breast cancer subtypes [50]. This evidence concerns the gene TNFRSF11B and breast carcinoma.